Medical Care

Global Anti-Senescence Therapy Market Insights, Forecast to 2030

Various biomolecules in the system have a large number of active groups, which must interact with each other to produce chemical reactions and slowly cross-link the biomolecules so as to stabilize the chemical activity.With the passage of time, the degree of crosslinking keeps increasing, the consumption of active groups of biological molecules keeps decreasing, and the original molecular structure gradually changes. The accumulation of these changes will gradually lead to the aging phenomenon of biological tissues.Anti-aging treatments include gene therapy, immunotherapy, attention to diseases of the elderly, and so on.
Market Analysis and Insights: Global Anti-Senescence Therapy Market
The global Anti-Senescence Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Anti-Senescence Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Anti-Senescence Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Anti-Senescence Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key companies of Anti-Senescence Therapy include Unity Biotechnology, Siwa Therapeutics, Calico LLC, AgeX Therapeutics，Inc, Numeric Biotech, Human Longevity, Inc. (HLI), Cleara Biotech, OisinBiotechnologies and Recursion Pharmaceuticals, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Anti-Senescence Therapy is widely used in various fields, such as Cardiovascular Diseases, Neural Degenerative Diseases, Ophthalmology Disorders and Others, etc. Cardiovascular Diseases provides greatest supports to the Anti-Senescence Therapy industry development. In 2023, global % revenue of Anti-Senescence Therapy went into Cardiovascular Diseases filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Anti-Senescence Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anti-Senescence Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Anti-Senescence Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-Senescence Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-Senescence Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Anti-Senescence Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Unity Biotechnology
Siwa Therapeutics
Calico LLC
AgeX Therapeutics，Inc
Numeric Biotech
Human Longevity, Inc. (HLI)
Cleara Biotech
OisinBiotechnologies
Recursion Pharmaceuticals
Sierra Sciences
Proteostasis Therapeutics
Senolytic Therapeutics
Allergan
Segment by Type
Gene Therapy
Immunotherapy
Others
Segment by Application
Cardiovascular Diseases
Neural Degenerative Diseases
Ophthalmology Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Anti-Senescence Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Senescence Therapy companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Senescence Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-Senescence Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Gene Therapy
1.2.3 Immunotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Anti-Senescence Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cardiovascular Diseases
1.3.3 Neural Degenerative Diseases
1.3.4 Ophthalmology Disorders
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-Senescence Therapy Market Perspective (2019-2030)
2.2 Global Anti-Senescence Therapy Growth Trends by Region
2.2.1 Anti-Senescence Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Anti-Senescence Therapy Historic Market Size by Region (2019-2024)
2.2.3 Anti-Senescence Therapy Forecasted Market Size by Region (2025-2030)
2.3 Anti-Senescence Therapy Market Dynamics
2.3.1 Anti-Senescence Therapy Industry Trends
2.3.2 Anti-Senescence Therapy Market Drivers
2.3.3 Anti-Senescence Therapy Market Challenges
2.3.4 Anti-Senescence Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Anti-Senescence Therapy by Players
3.1.1 Global Anti-Senescence Therapy Revenue by Players (2019-2024)
3.1.2 Global Anti-Senescence Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Anti-Senescence Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Anti-Senescence Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Anti-Senescence Therapy Market Concentration Ratio
3.4.1 Global Anti-Senescence Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-Senescence Therapy Revenue in 2023
3.5 Global Key Players of Anti-Senescence Therapy Head office and Area Served
3.6 Global Key Players of Anti-Senescence Therapy, Product and Application
3.7 Global Key Players of Anti-Senescence Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-Senescence Therapy Breakdown Data by Type
4.1 Global Anti-Senescence Therapy Historic Market Size by Type (2019-2024)
4.2 Global Anti-Senescence Therapy Forecasted Market Size by Type (2025-2030)
5 Anti-Senescence Therapy Breakdown Data by Application
5.1 Global Anti-Senescence Therapy Historic Market Size by Application (2019-2024)
5.2 Global Anti-Senescence Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Anti-Senescence Therapy Market Size (2019-2030)
6.2 North America Anti-Senescence Therapy Market Size by Type
6.2.1 North America Anti-Senescence Therapy Market Size by Type (2019-2024)
6.2.2 North America Anti-Senescence Therapy Market Size by Type (2025-2030)
6.2.3 North America Anti-Senescence Therapy Market Share by Type (2019-2030)
6.3 North America Anti-Senescence Therapy Market Size by Application
6.3.1 North America Anti-Senescence Therapy Market Size by Application (2019-2024)
6.3.2 North America Anti-Senescence Therapy Market Size by Application (2025-2030)
6.3.3 North America Anti-Senescence Therapy Market Share by Application (2019-2030)
6.4 North America Anti-Senescence Therapy Market Size by Country
6.4.1 North America Anti-Senescence Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Anti-Senescence Therapy Market Size by Country (2019-2024)
6.4.3 North America Anti-Senescence Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Anti-Senescence Therapy Market Size (2019-2030)
7.2 Europe Anti-Senescence Therapy Market Size by Type
7.2.1 Europe Anti-Senescence Therapy Market Size by Type (2019-2024)
7.2.2 Europe Anti-Senescence Therapy Market Size by Type (2025-2030)
7.2.3 Europe Anti-Senescence Therapy Market Share by Type (2019-2030)
7.3 Europe Anti-Senescence Therapy Market Size by Application
7.3.1 Europe Anti-Senescence Therapy Market Size by Application (2019-2024)
7.3.2 Europe Anti-Senescence Therapy Market Size by Application (2025-2030)
7.3.3 Europe Anti-Senescence Therapy Market Share by Application (2019-2030)
7.4 Europe Anti-Senescence Therapy Market Size by Country
7.4.1 Europe Anti-Senescence Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Anti-Senescence Therapy Market Size by Country (2019-2024)
7.4.3 Europe Anti-Senescence Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Anti-Senescence Therapy Market Size (2019-2030)
8.2 China Anti-Senescence Therapy Market Size by Type
8.2.1 China Anti-Senescence Therapy Market Size by Type (2019-2024)
8.2.2 China Anti-Senescence Therapy Market Size by Type (2025-2030)
8.2.3 China Anti-Senescence Therapy Market Share by Type (2019-2030)
8.3 China Anti-Senescence Therapy Market Size by Application
8.3.1 China Anti-Senescence Therapy Market Size by Application (2019-2024)
8.3.2 China Anti-Senescence Therapy Market Size by Application (2025-2030)
8.3.3 China Anti-Senescence Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Anti-Senescence Therapy Market Size (2019-2030)
9.2 Asia Anti-Senescence Therapy Market Size by Type
9.2.1 Asia Anti-Senescence Therapy Market Size by Type (2019-2024)
9.2.2 Asia Anti-Senescence Therapy Market Size by Type (2025-2030)
9.2.3 Asia Anti-Senescence Therapy Market Share by Type (2019-2030)
9.3 Asia Anti-Senescence Therapy Market Size by Application
9.3.1 Asia Anti-Senescence Therapy Market Size by Application (2019-2024)
9.3.2 Asia Anti-Senescence Therapy Market Size by Application (2025-2030)
9.3.3 Asia Anti-Senescence Therapy Market Share by Application (2019-2030)
9.4 Asia Anti-Senescence Therapy Market Size by Region
9.4.1 Asia Anti-Senescence Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Anti-Senescence Therapy Market Size by Region (2019-2024)
9.4.3 Asia Anti-Senescence Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Unity Biotechnology
11.1.1 Unity Biotechnology Company Details
11.1.2 Unity Biotechnology Business Overview
11.1.3 Unity Biotechnology Anti-Senescence Therapy Introduction
11.1.4 Unity Biotechnology Revenue in Anti-Senescence Therapy Business (2019-2024)
11.1.5 Unity Biotechnology Recent Developments
11.2 Siwa Therapeutics
11.2.1 Siwa Therapeutics Company Details
11.2.2 Siwa Therapeutics Business Overview
11.2.3 Siwa Therapeutics Anti-Senescence Therapy Introduction
11.2.4 Siwa Therapeutics Revenue in Anti-Senescence Therapy Business (2019-2024)
11.2.5 Siwa Therapeutics Recent Developments
11.3 Calico LLC
11.3.1 Calico LLC Company Details
11.3.2 Calico LLC Business Overview
11.3.3 Calico LLC Anti-Senescence Therapy Introduction
11.3.4 Calico LLC Revenue in Anti-Senescence Therapy Business (2019-2024)
11.3.5 Calico LLC Recent Developments
11.4 AgeX Therapeutics，Inc
11.4.1 AgeX Therapeutics，Inc Company Details
11.4.2 AgeX Therapeutics，Inc Business Overview
11.4.3 AgeX Therapeutics，Inc Anti-Senescence Therapy Introduction
11.4.4 AgeX Therapeutics，Inc Revenue in Anti-Senescence Therapy Business (2019-2024)
11.4.5 AgeX Therapeutics，Inc Recent Developments
11.5 Numeric Biotech
11.5.1 Numeric Biotech Company Details
11.5.2 Numeric Biotech Business Overview
11.5.3 Numeric Biotech Anti-Senescence Therapy Introduction
11.5.4 Numeric Biotech Revenue in Anti-Senescence Therapy Business (2019-2024)
11.5.5 Numeric Biotech Recent Developments
11.6 Human Longevity, Inc. (HLI)
11.6.1 Human Longevity, Inc. (HLI) Company Details
11.6.2 Human Longevity, Inc. (HLI) Business Overview
11.6.3 Human Longevity, Inc. (HLI) Anti-Senescence Therapy Introduction
11.6.4 Human Longevity, Inc. (HLI) Revenue in Anti-Senescence Therapy Business (2019-2024)
11.6.5 Human Longevity, Inc. (HLI) Recent Developments
11.7 Cleara Biotech
11.7.1 Cleara Biotech Company Details
11.7.2 Cleara Biotech Business Overview
11.7.3 Cleara Biotech Anti-Senescence Therapy Introduction
11.7.4 Cleara Biotech Revenue in Anti-Senescence Therapy Business (2019-2024)
11.7.5 Cleara Biotech Recent Developments
11.8 OisinBiotechnologies
11.8.1 OisinBiotechnologies Company Details
11.8.2 OisinBiotechnologies Business Overview
11.8.3 OisinBiotechnologies Anti-Senescence Therapy Introduction
11.8.4 OisinBiotechnologies Revenue in Anti-Senescence Therapy Business (2019-2024)
11.8.5 OisinBiotechnologies Recent Developments
11.9 Recursion Pharmaceuticals
11.9.1 Recursion Pharmaceuticals Company Details
11.9.2 Recursion Pharmaceuticals Business Overview
11.9.3 Recursion Pharmaceuticals Anti-Senescence Therapy Introduction
11.9.4 Recursion Pharmaceuticals Revenue in Anti-Senescence Therapy Business (2019-2024)
11.9.5 Recursion Pharmaceuticals Recent Developments
11.10 Sierra Sciences
11.10.1 Sierra Sciences Company Details
11.10.2 Sierra Sciences Business Overview
11.10.3 Sierra Sciences Anti-Senescence Therapy Introduction
11.10.4 Sierra Sciences Revenue in Anti-Senescence Therapy Business (2019-2024)
11.10.5 Sierra Sciences Recent Developments
11.11 Proteostasis Therapeutics
11.11.1 Proteostasis Therapeutics Company Details
11.11.2 Proteostasis Therapeutics Business Overview
11.11.3 Proteostasis Therapeutics Anti-Senescence Therapy Introduction
11.11.4 Proteostasis Therapeutics Revenue in Anti-Senescence Therapy Business (2019-2024)
11.11.5 Proteostasis Therapeutics Recent Developments
11.12 Senolytic Therapeutics
11.12.1 Senolytic Therapeutics Company Details
11.12.2 Senolytic Therapeutics Business Overview
11.12.3 Senolytic Therapeutics Anti-Senescence Therapy Introduction
11.12.4 Senolytic Therapeutics Revenue in Anti-Senescence Therapy Business (2019-2024)
11.12.5 Senolytic Therapeutics Recent Developments
11.13 Allergan
11.13.1 Allergan Company Details
11.13.2 Allergan Business Overview
11.13.3 Allergan Anti-Senescence Therapy Introduction
11.13.4 Allergan Revenue in Anti-Senescence Therapy Business (2019-2024)
11.13.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Anti-Senescence Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Gene Therapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Others
Table 5. Global Anti-Senescence Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global Anti-Senescence Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Anti-Senescence Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Anti-Senescence Therapy Market Share by Region (2019-2024)
Table 9. Global Anti-Senescence Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Anti-Senescence Therapy Market Share by Region (2025-2030)
Table 11. Anti-Senescence Therapy Market Trends
Table 12. Anti-Senescence Therapy Market Drivers
Table 13. Anti-Senescence Therapy Market Challenges
Table 14. Anti-Senescence Therapy Market Restraints
Table 15. Global Anti-Senescence Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Anti-Senescence Therapy Revenue Share by Players (2019-2024)
Table 17. Global Top Anti-Senescence Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Senescence Therapy as of 2023)
Table 18. Global Anti-Senescence Therapy Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by Anti-Senescence Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Anti-Senescence Therapy, Headquarters and Area Served
Table 21. Global Key Players of Anti-Senescence Therapy, Product and Application
Table 22. Global Key Players of Anti-Senescence Therapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-Senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Anti-Senescence Therapy Revenue Market Share by Type (2019-2024)
Table 26. Global Anti-Senescence Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Anti-Senescence Therapy Revenue Market Share by Type (2025-2030)
Table 28. Global Anti-Senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Anti-Senescence Therapy Revenue Share by Application (2019-2024)
Table 30. Global Anti-Senescence Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Anti-Senescence Therapy Revenue Share by Application (2025-2030)
Table 32. North America Anti-Senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America Anti-Senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America Anti-Senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America Anti-Senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America Anti-Senescence Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Anti-Senescence Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Anti-Senescence Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Anti-Senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe Anti-Senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe Anti-Senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe Anti-Senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe Anti-Senescence Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe Anti-Senescence Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe Anti-Senescence Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. China Anti-Senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 47. China Anti-Senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 48. China Anti-Senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 49. China Anti-Senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia Anti-Senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia Anti-Senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia Anti-Senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia Anti-Senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia Anti-Senescence Therapy Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia Anti-Senescence Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia Anti-Senescence Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Anti-Senescence Therapy Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 64. Unity Biotechnology Company Details
Table 65. Unity Biotechnology Business Overview
Table 66. Unity Biotechnology Anti-Senescence Therapy Product
Table 67. Unity Biotechnology Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 68. Unity Biotechnology Recent Developments
Table 69. Siwa Therapeutics Company Details
Table 70. Siwa Therapeutics Business Overview
Table 71. Siwa Therapeutics Anti-Senescence Therapy Product
Table 72. Siwa Therapeutics Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 73. Siwa Therapeutics Recent Developments
Table 74. Calico LLC Company Details
Table 75. Calico LLC Business Overview
Table 76. Calico LLC Anti-Senescence Therapy Product
Table 77. Calico LLC Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 78. Calico LLC Recent Developments
Table 79. AgeX Therapeutics，Inc Company Details
Table 80. AgeX Therapeutics，Inc Business Overview
Table 81. AgeX Therapeutics，Inc Anti-Senescence Therapy Product
Table 82. AgeX Therapeutics，Inc Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 83. AgeX Therapeutics，Inc Recent Developments
Table 84. Numeric Biotech Company Details
Table 85. Numeric Biotech Business Overview
Table 86. Numeric Biotech Anti-Senescence Therapy Product
Table 87. Numeric Biotech Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 88. Numeric Biotech Recent Developments
Table 89. Human Longevity, Inc. (HLI) Company Details
Table 90. Human Longevity, Inc. (HLI) Business Overview
Table 91. Human Longevity, Inc. (HLI) Anti-Senescence Therapy Product
Table 92. Human Longevity, Inc. (HLI) Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 93. Human Longevity, Inc. (HLI) Recent Developments
Table 94. Cleara Biotech Company Details
Table 95. Cleara Biotech Business Overview
Table 96. Cleara Biotech Anti-Senescence Therapy Product
Table 97. Cleara Biotech Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 98. Cleara Biotech Recent Developments
Table 99. OisinBiotechnologies Company Details
Table 100. OisinBiotechnologies Business Overview
Table 101. OisinBiotechnologies Anti-Senescence Therapy Product
Table 102. OisinBiotechnologies Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 103. OisinBiotechnologies Recent Developments
Table 104. Recursion Pharmaceuticals Company Details
Table 105. Recursion Pharmaceuticals Business Overview
Table 106. Recursion Pharmaceuticals Anti-Senescence Therapy Product
Table 107. Recursion Pharmaceuticals Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 108. Recursion Pharmaceuticals Recent Developments
Table 109. Sierra Sciences Company Details
Table 110. Sierra Sciences Business Overview
Table 111. Sierra Sciences Anti-Senescence Therapy Product
Table 112. Sierra Sciences Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 113. Sierra Sciences Recent Developments
Table 114. Proteostasis Therapeutics Company Details
Table 115. Proteostasis Therapeutics Business Overview
Table 116. Proteostasis Therapeutics Anti-Senescence Therapy Product
Table 117. Proteostasis Therapeutics Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 118. Proteostasis Therapeutics Recent Developments
Table 119. Senolytic Therapeutics Company Details
Table 120. Senolytic Therapeutics Business Overview
Table 121. Senolytic Therapeutics Anti-Senescence Therapy Product
Table 122. Senolytic Therapeutics Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 123. Senolytic Therapeutics Recent Developments
Table 124. Allergan Company Details
Table 125. Allergan Business Overview
Table 126. Allergan Anti-Senescence Therapy Product
Table 127. Allergan Revenue in Anti-Senescence Therapy Business (2019-2024) & (US$ Million)
Table 128. Allergan Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-Senescence Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Anti-Senescence Therapy Market Share by Type: 2023 VS 2030
Figure 3. Gene Therapy Features
Figure 4. Immunotherapy Features
Figure 5. Others Features
Figure 6. Global Anti-Senescence Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Anti-Senescence Therapy Market Share by Application: 2023 VS 2030
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Neural Degenerative Diseases Case Studies
Figure 10. Ophthalmology Disorders Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-Senescence Therapy Report Years Considered
Figure 13. Global Anti-Senescence Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Anti-Senescence Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Anti-Senescence Therapy Market Share by Region: 2023 VS 2030
Figure 16. Global Anti-Senescence Therapy Market Share by Players in 2023
Figure 17. Global Top Anti-Senescence Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-Senescence Therapy as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Anti-Senescence Therapy Revenue in 2023
Figure 19. North America Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Anti-Senescence Therapy Market Share by Type (2019-2030)
Figure 21. North America Anti-Senescence Therapy Market Share by Application (2019-2030)
Figure 22. North America Anti-Senescence Therapy Market Share by Country (2019-2030)
Figure 23. United States Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Anti-Senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Anti-Senescence Therapy Market Share by Type (2019-2030)
Figure 27. Europe Anti-Senescence Therapy Market Share by Application (2019-2030)
Figure 28. Europe Anti-Senescence Therapy Market Share by Country (2019-2030)
Figure 29. Germany Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Anti-Senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Anti-Senescence Therapy Market Share by Type (2019-2030)
Figure 37. China Anti-Senescence Therapy Market Share by Application (2019-2030)
Figure 38. Asia Anti-Senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Anti-Senescence Therapy Market Share by Type (2019-2030)
Figure 40. Asia Anti-Senescence Therapy Market Share by Application (2019-2030)
Figure 41. Asia Anti-Senescence Therapy Market Share by Region (2019-2030)
Figure 42. Japan Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Anti-Senescence Therapy Market Share by Country (2019-2030)
Figure 52. Brazil Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Anti-Senescence Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Unity Biotechnology Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 59. Siwa Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 60. Calico LLC Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 61. AgeX Therapeutics，Inc Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 62. Numeric Biotech Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 63. Human Longevity, Inc. (HLI) Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 64. Cleara Biotech Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 65. OisinBiotechnologies Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 66. Recursion Pharmaceuticals Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 67. Sierra Sciences Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 68. Proteostasis Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 69. Senolytic Therapeutics Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 70. Allergan Revenue Growth Rate in Anti-Senescence Therapy Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies